Frontiers in Oncology | Hematologic Malignancies

Original Research

Published on 26 Mar 2024

Decreasing the steroid rapidly may help to improve the clinical outcomes of patients with intestinal steroid-refractory acute graft-versus-host disease receiving basiliximab treatment

in Hematologic Malignancies

Cong Cheng
Dao-Xing Deng
Xiao-Hui Zhang
Lan-Ping Xu
Yu Wang
Chen-Hua Yan
Huan Chen
Yu-Hong Chen
Wei Han
Feng-Rong Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1390438

1,256 views

Case Report

Published on 25 Mar 2024

A case report of atypical chronic myeloid leukemia with complete hematological and major molecular response to Venetoclax/Azacitidine treatment

in Hematologic Malignancies

Hongxia Chen
Ning Wang
Yin Li
Xiaohong Xie
Yi Yang

Frontiers in Oncology

doi 10.3389/fonc.2024.1327834

1,529 views

Original Research

Published on 22 Mar 2024

TNF-α is a predictive marker in distinguishing myeloproliferative neoplasm and idiopathic erythrocytosis/thrombocytosis: development and validation of a non-invasive diagnostic model

in Hematologic Malignancies

Zhenhao Wang
Yu Mei
Zhuming Yang
Qiang Gao
Hao Xu
Zhiqiang Han
Zhenya Hong

Frontiers in Oncology

doi 10.3389/fonc.2024.1369346

1,579 views

Review

Published on 22 Mar 2024

Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma

in Hematologic Malignancies

Catarina Geraldes
Adriana Roque
Ana Bela Sarmento-Ribeiro
Manuel Neves
Alina Ionita
Rita Gerivaz
Ana Tomé
Sofia Afonso
Maria Pedro Silveira
Patrícia Sousa

Frontiers in Oncology

doi 10.3389/fonc.2024.1282300

4,247 views
2 citations

Original Research

Published on 21 Mar 2024

CD7-positive leukemic blasts with DNMT3A mutations predict poor prognosis in patients with acute myeloid leukemia

in Hematologic Malignancies

Yanliang Bai
Xiaobai Sun
Mengyi Li
Xiaona Niu
Weijie Cao
Junwei Niu
Xingjun Xiao
Yuqing Chen
Kai Sun

Frontiers in Oncology

doi 10.3389/fonc.2024.1342998

2,145 views

Review

Published on 21 Mar 2024

A comprehensive review of the role of bone marrow biopsy and PET-CT in the evaluation of bone marrow involvement in adults newly diagnosed with DLBCL

in Hematologic Malignancies

Ruah Alyamany
Riad El Fakih
Ahmed Alnughmush
Abdulwahab Albabtain
Mohamed A. Kharfan-Dabaja
Mahmoud Aljurf

Frontiers in Oncology

doi 10.3389/fonc.2024.1301979

4,625 views
2 citations

Original Research

Published on 20 Mar 2024

NUP214 fusion genes in acute leukemias: genetic characterization of rare cases

in Hematologic Malignancies

Marta Brunetti
Kristin Andersen
Signe Spetalen
Andrea Lenartova
Liv Toril Nygård Osnes
Helen Vålerhaugen
Sverre Heim
Francesca Micci

Frontiers in Oncology

doi 10.3389/fonc.2024.1371980

2,031 views

Review

Published on 20 Mar 2024

Inflammation as a driver of hematological malignancies

in Hematologic Malignancies

Sumedha Saluja
Ishu Bansal
Ruchi Bhardwaj
Mohammad Sabique Beg
Jayanth Kumar Palanichamy

Frontiers in Oncology

doi 10.3389/fonc.2024.1347402

4,776 views
8 citations

Case Report

Published on 20 Mar 2024

Case report: A familial B-acute lymphoblastic leukemia associated with a new germline pathogenic variant in PAX5. The first report in Mexico

in Hematologic Malignancies

Joaquín García-Solorio
Octavio Martínez-Villegas
Ulises Rodríguez-Corona
Carolina Molina-Garay
Marco Jiménez-Olivares
Karol Carrillo-Sanchez
Elvia C. Mendoza-Caamal
Anallely Muñoz-Rivas
Beatriz E. Villegas-Torres
Alejandra Cervera

Frontiers in Oncology

doi 10.3389/fonc.2024.1355335

1,923 views

Case Report

Published on 19 Mar 2024

Case report: One case of acute myeloid leukemia M3 with atypical morphology

in Hematologic Malignancies

Fa-Sheng Liu
Hua-Liang Huang

Frontiers in Oncology

doi 10.3389/fonc.2024.1341840

1,681 views

Original Research

Published on 18 Mar 2024

Prognostic significance of β2-microglobulin decline index in multiple myeloma

in Hematologic Malignancies

Tianyu Zhang
Zhili Lin
Ziwei Zheng
Quanqiang Wang
Shujuan Zhou
Bingxin Zhang
Dong Zheng
Zixing Chen
Sisi Zheng
Yu Zhang

Frontiers in Oncology

doi 10.3389/fonc.2024.1322680

1,900 views
1 citation

Original Research

Published on 15 Mar 2024

Risk factors analysis and the establishment of nomogram prediction model for PICC-related venous thrombosis in patients with lymphoma: a double-center cohort-based case-control study

in Hematologic Malignancies

Xuexing Wang
yuan He
jie Chu
Jin-Song Xu

Frontiers in Oncology

doi 10.3389/fonc.2024.1347297

2,261 views
2 citations

Review

Published on 15 Mar 2024

SKping cell cycle regulation: role of ubiquitin ligase SKP2 in hematological malignancies

in Hematologic Malignancies

Jonahunnatha Nesson George William
Ruby Dhar
Rohit Gundamaraju
Om Saswat Sahoo
Karthikeyan Pethusamy
A. F. P. Allwin Mabes Raj
Subbiah Ramasamy
Mohammed S. Alqahtani
Mohamed Abbas
Subhradip Karmakar

Frontiers in Oncology

doi 10.3389/fonc.2024.1288501

4,172 views
4 citations

Original Research

Published on 13 Mar 2024

Unraveling trajectories from aplastic anemia to hematologic malignancies: genetic and molecular insights

in Hematologic Malignancies

Namsoo Kim
Yu Jeong Choi
Seung-Tae Lee
Jong Rak Choi
Chuhl Joo Lyu
Saeam Shin
June-Won Cheong

Frontiers in Oncology

doi 10.3389/fonc.2024.1365614

2,173 views
1 citation

Systematic Review

Published on 13 Mar 2024

Patient-reported outcomes in Hodgkin lymphoma trials: a systematic review

in Hematologic Malignancies

Esther Natalie Oliva
Tatyana Ionova
Edward Laane
Mario Csenar
Julia Schroer
Karolin Behringer
Ina Monsef
Annika Oeser
Nicole Skoetz
Sam Salek

Frontiers in Oncology

doi 10.3389/fonc.2024.1353101

2,284 views

Case Report

Published on 11 Mar 2024

Composite diffuse large B-cell lymphoma and peripheral T-cell lymphoma: a case report with two-year follow-up and literature review

in Hematologic Malignancies

Jiwei Gu
Juan Qian
Xin Cao

Frontiers in Oncology

doi 10.3389/fonc.2024.1272209

2,159 views
2 citations